Showing posts with label mtor. Show all posts
Showing posts with label mtor. Show all posts
Tuesday, April 30, 2013

TRIPLE NEGATIVE BREAST CANCER TREATMENT

›
The reading about mechanisms of resistance of to Taxol calls for a new strategy for treatment of triple negative breast cancer; while it is ...
Friday, April 5, 2013

Nomenclature of 2 important genes in Ovarian cancer !

›
1.RASSF1A:   One of the thing cancer cell do is to Methylate some genes in order to block its path to death. it appears this gene is a cri...
Sunday, March 17, 2013

PANCREATIC CANCER GENE (CONTINUED)

›
1' KRT20: keratin related gene, most likely of an early expression in neoplastic transformation more predictive and diagnostic than of ...
Monday, March 11, 2013

ADVANCES IN METASTATIC RENAL CANCER

›
*IL-2  (High dose) Response rate < 10% but with rare cures * Medication approved 1. Sunitinib which was compred to Interferon to win ap...
Friday, March 8, 2013

INTERESTING DEBATES

›
1.NF1 Mutation is upstream from BRAF and MTOR But NF-1 is Mutated in Melanoma can infusion of protein resulting from NF-1 be used to str...
Tuesday, March 5, 2013

Molecules and Cancer Cells

›
Now that we know that the cell does not discriminate about what is the category of this molecule invading me as classified by humans, we are...
Sunday, February 24, 2013

NOMENCLATURE OF GENES TO LOOK FOR IN TRIPLE NEGATIVE BREAST CANCER

›
One may try to determine whether a breast cancer has bad prognosis in order to determine whether chemotherapy should be given (MammaPrint, O...
Friday, February 22, 2013

›
NEXT TO THE MTOR, We are getting closer to the cure every day, we are clearly at the door of the cure acquiring process, just learning th...
Monday, February 4, 2013

CELLULAR LANGUAGE (II)

›
In Cellular Language I published recently that we tried to emphasize that big functions of the cell start up with an on-and-off switch.  The...
Thursday, January 17, 2013

PUTTING THINGS TOGETHER IN TRIPLE NEGATIVE BREAST CANCER BRCA TESTING AND THE MTOR UNVEIL NEW PARADIGM SHIFT AT CRBCM

›
Now that we know that up to 85% of triple negative Breast cancers could have the BRCA Mutation in some cohort,  it is becoming a guideline s...